Malcolm W. MacNab
Hoofd Techniek/Wetenschap/O&O bij HaptoGuard, Inc.
Profiel
Malcolm W.
MacNab has served as Vice President of Clinical Development for Alteon, Inc. since July 2006.
Prior to joining Alteon, he served as Vice President of Clinical Development for HaptoGuard from 2004 to 2006.
From 1997 to 2004, Dr. MacNab served as Vice President of Cardiovascular and Metabolism Clinical Development and Medical Affairs at Novartis.
Prior to joining Novartis, he was Vice President in Cardiovascular Development at CIBA Pharmaceuticals.
Dr. MacNab received an MD and a PhD in Vascular Pharmacology from Temple University in Philadelphia and post-graduate training in Internal Medicine and Hematology at the Medical College of Pennsylvania.
Actieve functies van Malcolm W. MacNab
| Bedrijven | Functie | Begin |
|---|---|---|
HaptoGuard, Inc.
 HaptoGuard, Inc. BiotechnologyHealth Technology HaptoGuard, Inc. develops and commercializes therapeutics for inflammatory diseases. Its products include orally bioavailability and organ selenium mimics of glutathione peroxides that metabolize lipid peroxides. It develops products to research, diagnose, treat, and prevent diseases associated with damage from free radical and reactive oxygen species and diseases of oxidative stress. The company is headquartered in Fort Lee, NJ. | Hoofd Techniek/Wetenschap/O&O | - |
Eerdere bekende functies van Malcolm W. MacNab
| Bedrijven | Functie | Einde |
|---|---|---|
| SYNVISTA THERAPEUTICS, INC. | Corporate Officer/Principal | 31-12-2007 |
Novartis Corp.
 Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Corporate Officer/Principal | 01-01-2004 |
| Ciba Pharmaceuticals | Corporate Officer/Principal | - |
Opleiding van Malcolm W. MacNab
| Temple University (Pennsylvania) | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| SYNVISTA THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
HaptoGuard, Inc.
HaptoGuard, Inc. BiotechnologyHealth Technology HaptoGuard, Inc. develops and commercializes therapeutics for inflammatory diseases. Its products include orally bioavailability and organ selenium mimics of glutathione peroxides that metabolize lipid peroxides. It develops products to research, diagnose, treat, and prevent diseases associated with damage from free radical and reactive oxygen species and diseases of oxidative stress. The company is headquartered in Fort Lee, NJ. | Health Technology |
Novartis Corp.
Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Health Technology |
| Ciba Pharmaceuticals |